Furthermore, although our results are suggestive, further research will be needed on the possibility of employing pIRES-hrGFP-1a-Tph2-FLAG as a treatment for psychiatric diseases (e.g., major depression) involving a Tph2 dysfunction. Here, TPH2 is linked to major depressive disorder.